Politiparty
Politiparty

119th Congress Health

S. 229: DTC Act of 2025

Introduced

  1. Introduced (completed)Jan 23, 2025
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in Senate, Jan 23, 2025

Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025

This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.

Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.

Read the full summary

The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

9

Bipartisan support.

Who scored on this bill

6 points earned
  1. 1Richard Durbin D-IL SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Richard Durbin

History

  1. Jan 23, 2025Introduced in the Senate by Richard Durbin.
Show the full action history (2 actions)
  1. Jan 23, 2025Introduced in Senate
  2. Jan 23, 2025Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)